Piermont Capital Management Inc. - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 86 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$481,000
+117.6%
52,195
+138.4%
0.12%
+62.0%
Q1 2016$221,000
-53.5%
21,895
+4.0%
0.07%
-53.0%
Q4 2015$475,000
+27.3%
21,060
-6.4%
0.15%
+23.8%
Q3 2015$373,000
-26.3%
22,5000.0%0.12%
-20.3%
Q2 2015$506,00022,5000.15%
Other shareholders

There were no reported owners of ONCOMED PHARMACEUTICALS INC in Q2 2016.

NameSharesValueWeighting ↓
View complete list of ONCOMED PHARMACEUTICALS INC shareholders